ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES

by Ya. P. Dovgalevskiy, L. E. Kuvshinova, I. V. Graifer, N. V. Furman, P. Ya. Dovgalevskiy
Published 2016-01-01

ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION

by A. V. Rudakova
Published 2015-09-01

COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS

by V. A. Sulimov, D. A. Napalkov, A. A. Sokolova
Published 2015-09-01

NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY

by D. A. Napalkov, A. A. Sokolova
Published 2015-09-01

Perfil molecular em genes cyp3a4 e cyp2j2: um caminho para a farmacogenética do Rivaroxaban em uma população do Norte do Brasil

by TOSCANO, Paulo Martins
Published 2017

Gastrointestinal Bleeding and Direct Oral Anticoagulants among Patients with Atrial Fibrillation: Risk, Prevention, Management, and Quality of Life

by Paolo Zappulla, Valeria Calvi
Published 2021-04-01

Does atorvastatin therapy change the anti‐Xa activity in xabans‐treated patients with atrial fibrillation?

by Ingrid Škorňová, Matej Samoš, Tomáš Bolek, Lucia Stančiaková, Ľubica Vádelová, Peter Galajda, Ján Staško, Peter Kubisz, Marián Mokáň
Published 2021-05-01

Benefits and Harms of Low-Dose Rivaroxaban in Asian Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis of Real-World Studies

by Jun Qian, Yi-Dan Yan, Sheng-Yan Yang, Chi Zhang, Chi Zhang, Wen-Yan Li, Zhi-Chun Gu, Zhi-Chun Gu, Zhi-Chun Gu
Published 2021-05-01

A Diagnostic Solution for Lupus Anticoagulant Testing in Patients Taking Direct Oral FXa Inhibitors Using DOAC Filter

by Carine Farkh, Syrine Ellouze, Louis Gounelle, Mama Sad Houari, Jérôme Duchemin, Valérie Proulle, Michaela Fontenay, Michaela Fontenay, Xavier Delavenne, Xavier Delavenne, Georges Jourdi, Georges Jourdi, Georges Jourdi, Georges Jourdi
Published 2021-05-01

A patient with atrial fibrillation and comorbidities in clinical practice

by A. S. Skotnikov, E. A. Algiyan, Zh. M. Sizova
Published 2020-12-01

EFFICACY AND SAFETY OF THE ORAL ANTICOAGULANTS IN THE MANAGEMENT OF VENOUS THROMBOEMBOLISM: INDIRECT COMPARISON

by V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, D. V. Frolov, E. A. Ponomarev, A. S. Maslakov
Published 2016-12-01

Direct Oral Anticoagulants as Successful Treatment of Heparin-Induced Thrombocytopenia: A Parisian Retrospective Case Series

by Julie Carré, Julie Carré, Hippolyte Guérineau, Christine Le Beller, Christine Le Beller, Laëtitia Mauge, Laëtitia Mauge, Benoit Huynh, Roya Nili, Roya Nili, Benjamin Planquette, Benjamin Planquette, Sylvain Clauser, David M. Smadja, David M. Smadja, Dominique Helley, Dominique Helley, Agnès Lillo-Le Louet, Agnès Lillo-Le Louet, Nicolas Gendron, Nicolas Gendron, Leyla Calmette
Published 2021-08-01

The treatment of venous thromboembolism with new oral anticoagulants

by Davide Imberti
Published 2013-12-01

Direct oral anticoagulants in real practice: which doses for which patients. Limitations and bleeding risk compared to vitamin K antagonists

by Giancarlo Landini, Luca Masotti
Published 2013-12-01

Efficacy and Safety of Oral Anticoagulants in Patients with Systolic Heart Failure in Sinus Rhythm: A Systematic Review and Meta-analysis of Randomized Controlled Trials and Cohort...

by Marie H. Nygaard, Anne-Mette Hvas, Erik L. Grove
Published 2020-10-01

Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017

by Pamela L. Lutsey, Rob F. Walker, Richard F. MacLehose, Alvaro Alonso, Terrence J. Adam, Neil A. Zakai
Published 2019-10-01

Quantitative Systems Pharmacology Model-Based Predictions of Clinical Endpoints to Optimize Warfarin and Rivaroxaban Anti-Thrombosis Therapy

by Sonja Hartmann, Konstantinos Biliouris, Lawrence J. Lesko, Ulrike Nowak-Göttl, Mirjam N. Trame
Published 2020-07-01

Drug approval processes: A case study of rivaroxaban

by Sally A Arif, Zainab Bilfaqi
Published 2013-01-01

Effects of Verapamil and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban

by Minsoo Kim, Heebin Son, Keumhan Noh, Eunyoung Kim, Beom Soo Shin, Wonku Kang
Published 2019-03-01

An efficacy and safety study of rivaroxaban for the prevention of deep vein thrombosis in patients with left iliac vein compression treated with stent implantation (PLICTS): study...

by Miaomiao Li, Libin Zhang, Kaijie Zhang, Yuefeng Zhu, Zhenyu Shi, Wan Zhang, Bin Gao, Lubin Li, Zhengdong Fang, Li Yin, Bing Chen, Zhenjie Liu
Published 2020-09-01